US2013157976A1PendingUtilityA1
Novel pyridopyrazines and their use as modulators of kinases
Est. expiryNov 11, 2025(expired)· nominal 20-yr term from priority
Inventors:Eckhard ClausIrene SeipeltEckhard GuentherEmmanuel PolymeropoulosMichael P. CzechTilmann Schuster
A61P 9/10A61K 31/695A61K 31/675A61K 31/4985A61P 17/06A61K 31/5377A61P 1/16C07D 487/04
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general formulae (I) and (II), and to their preparation and use as medicaments, especially for the treatment of malignant disorders and other disorders based on pathological cell proliferations.
Claims
exact text as granted — not AI-modified1 - 60 . (canceled)
61 . A method of treating a physiological and/or pathological condition in a mammal mediated by two or more enzymes, the method comprising administering an effective amount of at least one pyrido[2,3-b]pyrazine derivative to the mammal;
wherein said physiological and/or pathophysiological states are selected from the group consisting of malignant tumours, inflammatory disorders, inflammations, rheumatic disorders, arthritic disorders, HIV infections, rheumatism, arthritis, AIDS, ARC (AIDS related complex), Kaposi's sarcoma, tumours emanating from the brain and/or nervous system and/or meninges, dementia, Alzheimer's, hyperproliferative disorders, colon tumour, stomach tumour, intestine tumour, lung tumour, pancreas tumour, ovarial tumour, prostate tumour, leukaemia, melanoma, liver tumour, kidney tumour, head tumour, throat tumour, glioma, breast tumour, uterine cancer, endometrial cancer, cervical cancer, brain tumour, adenocanthoma, bladder cancer, colorectal tumour, oesophageal cancer, gynaecological tumour, ovarian tumour, thyroid cancer, lymphoma, chronic leukaemia, acute leukaemia, diabetes, disorders of the metabolism, solid tumours, rheumatoid arthritis, allergies, allergic disorders, atherosclerosis, cardiac disorders, cardiovascular disorders, angiogenetic disorders, ischaemia, cardiac hypertrophy, obesity, excess weight, hypertension, wherein said mediation by two or more enzymes is an inhibition of two or more enzymes, wherein at least one enzyme is selected from the group consisting of: “Erk, Erk1, Erk2” and at least one enzyme is selected from the group consisting of: “PI3K, PI3Kalpha, PI3Kbeta, PI3Kgamma, PI3Kdelta, PI3K-C2alpha, PI3K-C2beta, PI3K-Vps34p, wherein said pyrido[2,3-b]pyrazine derivative is selected according to formula II
where the substituents R1-R4 have the following meaning:
R2 and R4: hydrogen
R1 is substituted heteroaryl, where:
the heteroaryl radical has one or more, identical or different, substituents selected from the group consisting of
(i) NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH 2 , NH-alkyl-OH, N(alkyl) 2 , NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, S-alkyl, S-aryl, S-heteroaryl, O-alkyl, O-cycloalkyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkyl-cycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl substituents,
with the proviso that
the alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl substituents from group (i) in turn themselves have one or more, identical or different, substituents selected from the group consisting of:
(ii) NH-cycloalkyl, NH-heterocyclyl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH 2 , NH-alkyl-OH, NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, S-aryl, S-heteroaryl, O-cycloalkyl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkyl-cycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)—NH 2 , C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , SO 2 NH 2 , SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkyl-aryl, cycloalkyl, heterocyclyl, aryl or heteroaryl,
where the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl radicals listed in group (ii) may in turn themselves have one or more, same or different, substituents selected from the group consisting of:
(iii) H, F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 -alkyl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 ,
R3 is NR9R10,
where R9 may be
(iv) hydrogen, alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkyl-cycloalkyl, alkyl-heterocyclyl, alkyl-aryl or alkyl-heteroaryl, where the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl radicals listed in group
(iv) may in turn themselves have one or more, same or different, substituents selected from the group consisting of
(v) H, F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 ,
and R10 may be
(A) —C(Y)NR11R12, where Y is O or S
and R11 and R12 may be independently of one another
(vi) hydrogen,
(vii) unsubstituted or substituted alkyl, where the alkyl radical may have one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF 3 , CN, NH 2 , NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, N(alkyl) 2 , NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, NO 2 , SH, S-alkyl, S-cycloalkyl, S-heterocyclyl, S-aryl, S-heteroaryl, OH, OCF 3 , O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 3 H, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, OP(O)(OH) 2 , C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 H, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkyl-cycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)—NH 2 , C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , SO-alkyl, SO-aryl, SO 2 -alkyl, SO 2 -aryl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 3 H, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkyl-aryl, cycloalkyl, heterocyclyl, aryl or heteroaryl,
(viii) unsubstituted or substituted cycloalkyl, where the cycloalkyl radical may have one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, NH 2 , NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-aryl, NH-alkyl-heteroaryl, N(alkyl) 2 , NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, OH, O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 3 H, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, OP(O)(OH) 2 , CO 2 H, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkylcycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)—NH 2 , C(O)NH-aryl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , alkyl or aryl,
(ix) unsubstituted or substituted heterocyclyl, where the heterocyclyl radical may have one or more, identical or different, substituents selected from the group consisting of OH, O-alkyl, O-aryl, NH 2 , NH-alkyl, NH-aryl, alkyl, alkyl-aryl or aryl,
(x) unsubstituted or substituted aryl, where the aryl radical may have one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF 3 , CN, NH 2 , NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH 2 , NH-alkyl-OH, N(alkyl) 2 , NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, NO 2 , SH, S-alkyl, S-cycloalkyl, S-heterocyclyl, S-aryl, S-heteroaryl, OH, OCF 3 , O-alkyl, O-cycloalkyl, O-heterocyclyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, O-alkyl-OH, O—(CH 2 ) n —O (n=1, 2 or 3), OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 3 H, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, OP(O)(OH) 2 , C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 H, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkyl-cycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)—NH 2 , C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , SO-alkyl, SO-aryl, SO 2 -alkyl, SO 2 -aryl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 3 H, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkylaryl, alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl,
(xi) unsubstituted or substituted heteroaryl, where the heteroaryl radical may have one or more, identical or different, substituents selected from the group consisting of F, Cl, Br, I, CF 3 , CN, NH 2 , NH-alkyl, NH-cycloalkyl, NH-heterocyclyl, NH-aryl, NH-heteroaryl, NH-alkyl-cycloalkyl, NH-alkyl-heterocyclyl, NH-alkyl-aryl, NH-alkyl-heteroaryl, NH-alkyl-NH 2 , NH-alkyl-OH, N(alkyl) 2 , NHC(O)-alkyl, NHC(O)-cycloalkyl, NHC(O)-heterocyclyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHC(O)-alkyl-aryl, NHC(O)-alkyl-heteroaryl, NHSO 2 -alkyl, NHSO 2 -cycloalkyl, NHSO 2 -heterocyclyl, NHSO 2 -aryl, NHSO 2 -heteroaryl, NHSO 2 -alkyl-aryl, NHSO 2 -alkyl-heteroaryl, NO 2 , SH, S-alkyl, S-aryl, S-heteroaryl, OH, OCF 3 , O-alkyl, O-cycloalkyl, O-aryl, O-heteroaryl, O-alkyl-cycloalkyl, O-alkyl-heterocyclyl, O-alkyl-aryl, O-alkyl-heteroaryl, OC(O)-alkyl, OC(O)-cycloalkyl, OC(O)-heterocyclyl, OC(O)-aryl, OC(O)-heteroaryl, OC(O)-alkyl-aryl, OC(O)-alkyl-heteroaryl, OSO 3 H, OSO 2 -alkyl, OSO 2 -cycloalkyl, OSO 2 -heterocyclyl, OSO 2 -aryl, OSO 2 -heteroaryl, OSO 2 -alkyl-aryl, OSO 2 -alkyl-heteroaryl, OP(O)(OH) 2 , C(O)-alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 H, CO 2 -alkyl, CO 2 -cycloalkyl, CO 2 -heterocyclyl, CO 2 -aryl, CO 2 -heteroaryl, CO 2 -alkyl-cycloalkyl, CO 2 -alkyl-heterocyclyl, CO 2 -alkyl-aryl, CO 2 -alkyl-heteroaryl, C(O)—NH 2 , C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, C(O)N(alkyl) 2 , C(O)N(cycloalkyl) 2 , C(O)N(aryl) 2 , C(O)N(heteroaryl) 2 , SO 2 NH 2 , SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 3 H, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl,
(xii) —C(O)—R17, where R17 may be alkyl, aryl or heteroaryl, and where alkyl and aryl may in turn themselves have one or more, same or different, substituents selected from the group consisting of
F, Cl, Br, I, CN, CF 3 , NH 2 , NH-alkyl, NH-aryl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , O-alkyl, O-aryl, OSO 3 H, OP(O)(OH) 2 , CHO, CO 2 H, SO 3 H or alkyl.
(xiii) or R11 and R12 together may be cycloalkyl or heterocyclyl.
62 . The method of claim 61 , wherein
R1 is selected from the group consisting of (i) pyrrolyl, furyl, thienyl, thiazolyl, oxazolyl, isoxazolyl, pyrazolyl, imidazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, phthalazinyl, indolyl, indazolyl, indolizinyl, quinolinyl, isoquinolinyl, quinoxalinyl, quinazolinyl, carbazolyl, phenazinyl, phenothiazinyl, acridinyl,
where the heteroaryl radicals listed in group (i) are substituted once with a radical selected from the group consisting of
(ii) C(O)NH-alkyl, C(O)NH-cycloalkyl, C(O)NH-heterocyclyl, C(O)NH-aryl, C(O)NH-heteroaryl, C(O)NH-alkyl-cycloalkyl, C(O)NH-alkyl-heterocyclyl, C(O)NH-alkyl-aryl, C(O)NH-alkyl-heteroaryl, SO 2 NH-alkyl, SO 2 NH-aryl, SO 2 NH-heteroaryl, SO 2 NH-alkyl-aryl, SO 2 O-alkyl, SO 2 O-aryl, SO 2 O-alkyl-aryl, alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl substituents, with the proviso, that
the heteroaryl radicals listed in group (ii) in turn themselves have one or more, same or different, substituents selected from the group consisting of
(iii) NH-alkyl, N(alkyl) 2 , S-alkyl, O-alkyl, alkyl, alkyl-OH, alkyl-NH 2 , alkyl-SH, alkyl-O-alkyl, alkyl-O—[(CH 2 ) n —O] m , (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH-alkyl, alkyl-N-(alkyl) 2 , alkyl-S-alkyl, C(O)-alkyl, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 2 -alkyl, SO 2 NH-alkyl, SO 2 N(alkyl) 2 , alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl,
and where the alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl radicals listed in group (iii) may in turn themselves have one or more, same or different, substituents selected from the group consisting of
(iv) H, F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH 2 ) n —O] m , (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 -alkyl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 , R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl where the alkyl radical may be selected from the group consisting of (v) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, iso-pentyl, neo-pentyl, n-hexyl, 2-hexyl, n-heptyl, n-octyl, ethylenyl (vinyl), ethynyl, propenyl (—CH 2 CH═CH 2 , —CH═CH—CH 3 , —C(═CH 2 )—CH 3 ), propynyl (—CH 2 —C≡CH, —C≡C—CH 3 ), butenyl, butynyl, pentenyl, pentynyl, hexenyl, hexynyl, heptenyl, heptynyl, octenyl, octynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, and where the radicals listed in group (v) may in turn themselves have one or more, same or different, substituents selected from the group consisting of (vii) F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 -alkyl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 .
63 . The method of claim 61 , wherein
R1 is pyrazolyl, with the proviso that the pyrazolyl radical is substituted one or more times with an alkyl-aryl substituent, where the alkyl-aryl radicals in turn themselves may have one or more, same or different, substituents selected from the group consisting of (i) H, F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 -alkyl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 , R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl where the alkyl radical may be selected from the group consisting of (ii) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, ethylenyl (vinyl), ethynyl, propenyl (—CH 2 CH═CH 2 , —CH═CH—CH 3 , —C(═CH 2 )—CH 3 ), propynyl (—CH 2 —C|CH, —C≡C—CH 3 ), butenyl, butynyl, cyclopropyl, cyclobutyl,
and where the radicals listed in group (ii) may in turn themselves have one or more, same or different, substituents selected from the group consisting of
(iii) F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 -alkyl, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 .
64 . The method of claim 61 , wherein
R1 is (1-benzyl)pyrazol-4-yl where the 1-benzyl radical in turn itself may have one or more, same or different, substituents selected from the group consisting of (i) F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m—1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 , R3 is NHC(O)NH-alkyl or NHC(S)NH-alkyl where the alkyl radical may be selected from the group consisting of (i) methyl, ethyl, n-propyl, 2-propyl, n-butyl, sec-butyl, ethylenyl (vinyl), ethynyl, propenyl (—CH 2 CH═CH 2 , —CH═CH—CH 3 , —C(═CH 2 )—CH 3 ), propynyl (—CH 2 —C≡CH, —C≡C—CH 3 ), cyclopropyl, cyclobutyl
and where the radicals listed in group (i) may in turn themselves have one or more, same or different, substituents selected from the group consisting of
(ii) F, Cl, Br, I, CF 3 , CHF 2 , CN, NH 2 , NH-alkyl, N(alkyl) 2 , NO 2 , SH, S-alkyl, OH, OCF 3 , OCHF 2 , O-alkyl, alkyl, alkyl-OH, alkyl-O-alkyl, alkyl-O—[(CH 2 ) n —O] m (n=1, 2 or 3, m=1, 2 or 3), alkyl-NH 2 , alkyl-NH-alkyl, alkyl-N(alkyl) 2 , CH(O), C(O)-alkyl, CO 2 H, CO 2 -alkyl, C(O)—NH 2 , C(O)NH-alkyl, C(O)N(alkyl) 2 , SO 3 H, SO 2 NH 2 , SO 2 NH-alkyl, SO 2 N(alkyl) 2 .Join the waitlist — get patent alerts
Track US2013157976A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.